Immuno Oncology Talks
Immuno Oncology Talks
Sanofi
Looking into the horizon of CAR-T cell therapies
33 minutes Posted Apr 8, 2024 at 11:00 am.
0:00
33:51
Download MP3
Show notes
In the current episode of “Immuno Oncology Talks”, we discuss the clinical challenges and future perspectives of CAR-T cells with our experts, from the Oslo University Hospital in Norway, Dr Else Marit Inderberg and Dr Sébastien Wälchli. Dr Inderberg is the head of the immunomonitoring at the hospital and has a research focus on novel immunotherapies, and Dr Wälchli is leading the CAR development platform. MAT-BE-2400334 (ver.1.0) 04 2024